Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
暂无分享,去创建一个
[1] C. Deutsch,et al. Metabolic changes in activated T cells: An NMR study of human peripheral blood lymphocytes , 1993, Magnetic resonance in medicine.
[2] R. Scollay. Immunology: Control of T-cell development , 1985, Nature.
[3] Jun O. Liu,et al. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth , 2008, Proceedings of the National Academy of Sciences.
[4] J. Rathmell,et al. Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.
[5] Kristen N. Pollizzi,et al. A modified model of T-cell differentiation based on mTOR activity and metabolism. , 2013, Cold Spring Harbor symposia on quantitative biology.
[6] Hongbo Chi,et al. S1P1-mTOR axis directs the reciprocal differentiation of TH1 and regulatory T cells , 2010, Nature Immunology.
[7] David K. Finlay,et al. AMPKα1: A glucose sensor that controls CD8 T-cell memory , 2013, European journal of immunology.
[8] A. Kirk,et al. Sirolimus Enhances the Magnitude and Quality of Viral‐Specific CD8+ T‐Cell Responses to Vaccinia Virus Vaccination in Rhesus Macaques , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] Robbie Loewith,et al. Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 , 2009, PLoS biology.
[10] B. Viollet,et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.
[11] G. de la Rosa,et al. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. , 2007, International immunopharmacology.
[12] C. Hess,et al. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch , 2013, Nature Immunology.
[13] M. Munday. Regulation of mammalian acetyl-CoA carboxylase. , 2002, Biochemical Society transactions.
[14] T. Horvath,et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. , 2010, Immunity.
[15] Takla Griss,et al. The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism , 2011, The Journal of Immunology.
[16] T. Gajewski,et al. Glucose Availability Regulates IFN-γ Production and p70S6 Kinase Activation in CD8+ Effector T Cells1 , 2005, The Journal of Immunology.
[17] E. Clambey,et al. Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa , 2012, Proceedings of the National Academy of Sciences.
[18] Y. Gwack,et al. Orai1-NFAT signalling pathway triggered by T cell receptor stimulation , 2013, Molecules and cells.
[19] T. Graeber,et al. The sterol regulatory element binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity , 2013, Nature Immunology.
[20] G. V. D. van der Windt,et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. , 2012, Immunity.
[21] Jennifer E. Van Eyk,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2016 .
[22] S. Weinhouse. On respiratory impairment in cancer cells. , 1956, Science.
[23] R. Schwartz. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy , 1992, Cell.
[24] J. Stockman. Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease , 2011 .
[25] C. Bassing,et al. Dynamic regulation of c‐Myc proto‐oncogene expression during lymphocyte development revealed by a GFP‐c‐Myc knock‐in mouse , 2008, European journal of immunology.
[26] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[27] B. Turk,et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.
[28] Mark S. Sundrud,et al. Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. , 2014, Immunity.
[29] M. Horton,et al. The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex , 2014, Nature Immunology.
[30] G. Semenza,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Moyer,et al. Human TH17 Cells Are Long-Lived Effector Memory Cells , 2011, Science Translational Medicine.
[32] D. Hardie,et al. Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes , 2006, The Journal of experimental medicine.
[33] T. Gajewski,et al. Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells , 2008, European journal of immunology.
[34] Kathryn A. O’Donnell,et al. Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.
[35] Jonathan D. Powell,et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. , 2009, The New England journal of medicine.
[36] T. Suda,et al. Dynamic regulation of Th17 differentiation by oxygen concentrations. , 2012, International immunology.
[37] A. Waickman,et al. mTOR, metabolism, and the regulation of T‐cell differentiation and function , 2012, Immunological reviews.
[38] Lieping Chen,et al. Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.
[39] A. Khoruts,et al. De novo induction of antigen‐specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR , 2008, Journal of leukocyte biology.
[40] G. Semenza,et al. Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.
[41] Peter Tontonoz,et al. LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response , 2008, Cell.
[42] J. Asara,et al. Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1 , 2013, Science.
[43] Dan R. Littman,et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity , 2011, Nature.
[44] S. Mineishi,et al. Characterization of the Metabolic Phenotype of Rapamycin-Treated CD8+ T Cells with Augmented Ability to Generate Long-Lasting Memory Cells , 2011, PloS one.
[45] A. Rao,et al. Calcineurin Binds the Transcription Factor NFAT1 and Reversibly Regulates Its Activity (*) , 1996, The Journal of Biological Chemistry.
[46] R. Ahmed,et al. mTOR regulates memory CD8 T cell differentiation , 2009, Nature.
[47] G. Ghosh,et al. Regulation of DNA binding by Rel/NF-κB transcription factors: structural views , 1999, Oncogene.
[48] D. Sabatini,et al. An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.
[49] S. Kern,et al. Th17 cells are long lived and retain a stem cell-like molecular signature. , 2011, Immunity.
[50] W. Havran,et al. Activation and function of γδ T cells , 1994 .
[51] Yong Zhao,et al. TSC1/2 Signaling Complex Is Essential for Peripheral Naïve CD8+ T Cell Survival and Homeostasis in Mice , 2012, PloS one.
[52] D. Sabatini,et al. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.
[53] A. Trumpp,et al. c-Myc acts downstream of IL-15 in the regulation of memory CD8 T-cell homeostasis. , 2006, Blood.
[54] C. Thompson,et al. The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.
[55] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[56] Jose Russo,et al. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. , 2012, Biochimica et biophysica acta.
[57] C. Dang,et al. Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.
[58] Russell G. Jones,et al. Revving the engine: signal transduction fuels T cell activation. , 2007, Immunity.
[59] Qingsheng Li,et al. A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. , 2011, Immunity.
[60] S. Gerondakis,et al. NF-κB control of T cell development , 2013, Nature Immunology.
[61] H. Schild,et al. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells , 2005, The Journal of experimental medicine.
[62] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[63] M. Battaglia,et al. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.
[64] Qingsheng Li,et al. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. , 2010, Immunity.
[65] T. P. Neufeld,et al. Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.
[66] Feng Liu,et al. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. , 2013, Cell metabolism.
[67] Linda V. Sinclair,et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation , 2013, Nature Immunology.
[68] Qicheng Ma,et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. , 2010, Molecular cell.
[69] J. Soulillou,et al. Mechanistic target of rapamycin inhibitors in solid organ transplantation: from benchside to clinical use , 2012, Current opinion in organ transplantation.
[70] M. Abecassis,et al. Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients , 2013, Hepatology.
[71] Peter Vogel,et al. mTORC1 couples immune signals and metabolic programming to establish Treg cell function , 2013, Nature.
[72] D. Hardie. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. , 2011, Genes & development.
[73] B. Viollet,et al. AMP‐activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function , 2008, European journal of immunology.
[74] J. Rathmell,et al. Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways1 , 2008, The Journal of Immunology.
[75] V. Zinzalla,et al. Activation of mTORC2 by Association with the Ribosome , 2011, Cell.
[76] S. Ito,et al. Structural Basis of Digoxin That Antagonizes RORγt Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production , 2011, The Journal of Biological Chemistry.
[77] B. Faubert,et al. CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability , 2013, Proceedings of the National Academy of Sciences.
[78] Shailendra Giri,et al. Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis1 , 2009, The Journal of Immunology.
[79] D. Sabatini,et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.
[80] A. Weiss,et al. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines , 2001, Nature Immunology.
[81] C. Dang. MYC, metabolism, cell growth, and tumorigenesis. , 2013, Cold Spring Harbor perspectives in medicine.
[82] Christopher C. Goodnow,et al. Differential activation of transcription factors induced by Ca2+ response amplitude and duration , 1997, Nature.
[83] Kun-Liang Guan,et al. Nutrient sensing, metabolism, and cell growth control. , 2013, Molecular cell.
[84] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[85] C. Bernstein,et al. Novel Anti-Inflammatory Action of 5-Aminoimidazole-4-carboxamide Ribonucleoside with Protective Effect in Dextran Sulfate Sodium-Induced Acute and Chronic Colitis , 2010, Journal of Pharmacology and Experimental Therapeutics.
[86] T. F. O’Brien,et al. Regulation of T‐cell survival and mitochondrial homeostasis by TSC1 , 2011, European journal of immunology.
[87] V. Mootha,et al. mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.
[88] R. Deberardinis,et al. Phosphatidylinositol 3-Kinase-dependent Modulation of Carnitine Palmitoyltransferase 1A Expression Regulates Lipid Metabolism during Hematopoietic Cell Growth* , 2006, Journal of Biological Chemistry.
[89] M. Gassmann,et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.
[90] U. Sauer,et al. Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis , 2013, Science.
[91] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[92] C. Spencer,et al. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. , 2010, Immunity.
[93] E. Yang,et al. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen , 2013, Nature Immunology.
[94] D. Green,et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.
[95] B. Faubert,et al. Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.
[96] Ming-Rong Wang,et al. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth , 2011, Proceedings of the National Academy of Sciences.
[97] V. Kuchroo,et al. Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen‐Specific Regulatory T Cells , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[98] E. Gilboa,et al. Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity. , 2014, The Journal of clinical investigation.
[99] G. Semenza. Regulation of metabolism by hypoxia-inducible factor 1. , 2011, Cold Spring Harbor symposia on quantitative biology.
[100] P. Fields,et al. Blocked Ras Activation in Anergic CD4+ T Cells , 1996, Science.
[101] P. Worley,et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.
[102] D. Sabatini,et al. Regulation of mTORC1 and its impact on gene expression at a glance , 2013, Journal of Cell Science.
[103] G. Keren,et al. Hypoxia controls CD4+CD25+ regulatory T‐cell homeostasis via hypoxia‐inducible factor‐1α , 2008, European journal of immunology.
[104] R. Wenger,et al. Cutting Edge: Hypoxia-Inducible Factor 1α and Its Activation-Inducible Short Isoform I.1 Negatively Regulate Functions of CD4+ and CD8+ T Lymphocytes , 2006, The Journal of Immunology.
[105] K. Frauwirth,et al. Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation , 2010, The Journal of Immunology.
[106] A. Ohta,et al. Genetic deletion of the HIF‐1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model , 2013, European journal of immunology.
[107] Anjana Rao,et al. Transcriptional Mechanisms Underlying Lymphocyte Tolerance , 2002, Cell.
[108] K. Frauwirth,et al. Regulation of T lymphocyte metabolism , 2004, Brain, Behavior, and Immunity.
[109] P. Muranski,et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. , 2013, The Journal of clinical investigation.
[110] C. Benoist,et al. The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells , 2008, The Journal of experimental medicine.
[111] Takla Griss,et al. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α , 2014, Proceedings of the National Academy of Sciences.
[112] M. Celeste Simon,et al. O2 regulates stem cells through Wnt/β-catenin signalling , 2010, Nature Cell Biology.
[113] P. Worley,et al. The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.
[114] D. Green,et al. HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.
[115] J. Greenbaum,et al. Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors , 2012, Proceedings of the National Academy of Sciences.
[116] Shailendra Giri,et al. 5-Aminoimidazole-4-Carboxamide Ribonucleoside: A Novel Immunomodulator with Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.
[117] David K. Finlay,et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells , 2012, The Journal of experimental medicine.
[118] R. Schwartz,et al. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. , 1999, Journal of immunology.
[119] J. Rathmell,et al. Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.
[120] G. Semenza,et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.
[121] A. Hirao,et al. PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ. , 2021, Cell reports.
[122] R. Schwartz,et al. Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.
[123] J. Powell,et al. Dissecting the mechanism of T-cell anergy with immunophilin ligands. , 2006, Current opinion in investigational drugs.
[124] Russell G. Jones,et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.
[125] R. Schwartz,et al. Models of T Cell Anergy: Is There a Common Molecular Mechanism? , 1996 .
[126] D. Guertin,et al. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. , 2013, Immunity.
[127] N. Denko,et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.